337 related articles for article (PubMed ID: 23621985)
21. mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.
Mashima T; Taneda Y; Jang MK; Mizutani A; Muramatsu Y; Yoshida H; Sato A; Tanaka N; Sugimoto Y; Seimiya H
Oncotarget; 2017 Jul; 8(29):47902-47915. PubMed ID: 28615517
[TBL] [Abstract][Full Text] [Related]
22. A Context-Dependent Role for the RNF146 Ubiquitin Ligase in Wingless/Wnt Signaling in
Wang Z; Tacchelly-Benites O; Noble GP; Johnson MK; Gagné JP; Poirier GG; Ahmed Y
Genetics; 2019 Mar; 211(3):913-923. PubMed ID: 30593492
[TBL] [Abstract][Full Text] [Related]
23. Tankyrases maintain homeostasis of intestinal epithelium by preventing cell death.
Ye P; Chiang YJ; Qi Z; Li Y; Wang S; Liu Y; Li X; Chen YG
PLoS Genet; 2018 Sep; 14(9):e1007697. PubMed ID: 30260955
[TBL] [Abstract][Full Text] [Related]
24. Wnt/Wingless Pathway Activation Is Promoted by a Critical Threshold of Axin Maintained by the Tumor Suppressor APC and the ADP-Ribose Polymerase Tankyrase.
Wang Z; Tacchelly-Benites O; Yang E; Thorne CA; Nojima H; Lee E; Ahmed Y
Genetics; 2016 May; 203(1):269-81. PubMed ID: 26975665
[TBL] [Abstract][Full Text] [Related]
25. Tankyrase Promotes Aerobic Glycolysis and Proliferation of Ovarian Cancer through Activation of Wnt/
Yang HY; Shen JX; Wang Y; Liu Y; Shen DY; Quan S
Biomed Res Int; 2019; 2019():2686340. PubMed ID: 30915350
[TBL] [Abstract][Full Text] [Related]
26. The ADP-ribose polymerase Tankyrase regulates adult intestinal stem cell proliferation during homeostasis in Drosophila.
Wang Z; Tian A; Benchabane H; Tacchelly-Benites O; Yang E; Nojima H; Ahmed Y
Development; 2016 May; 143(10):1710-20. PubMed ID: 27190037
[TBL] [Abstract][Full Text] [Related]
27. Tankyrase Regulates Neurite Outgrowth through Poly(ADP-ribosyl)ation-Dependent Activation of β-Catenin Signaling.
Mashimo M; Kita M; Uno A; Nii M; Ishihara M; Honda T; Gotoh-Kinoshita Y; Nomura A; Nakamura H; Murayama T; Kizu R; Fujii T
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269974
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation.
Cheng H; Li X; Wang C; Chen Y; Li S; Tan J; Tan B; He Y
Cancer Lett; 2019 Feb; 443():80-90. PubMed ID: 30472184
[TBL] [Abstract][Full Text] [Related]
29. Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer.
Yang J; Zhang X; Chen Z; Shen Y; Wang F; Wang Y; Liu Y; Liu P; Yang J
Cell Death Dis; 2019 Feb; 10(3):179. PubMed ID: 30792381
[TBL] [Abstract][Full Text] [Related]
30. Wnt pathway activation by ADP-ribosylation.
Yang E; Tacchelly-Benites O; Wang Z; Randall MP; Tian A; Benchabane H; Freemantle S; Pikielny C; Tolwinski NS; Lee E; Ahmed Y
Nat Commun; 2016 May; 7():11430. PubMed ID: 27138857
[TBL] [Abstract][Full Text] [Related]
31. Discovery of Novel Inhibitor for WNT/β-Catenin Pathway by Tankyrase 1/2 Structure-Based Virtual Screening.
Li B; Liang J; Lu F; Zeng G; Zhang J; Ma Y; Liu P; Wang Q; Zhou Q; Chen L
Molecules; 2020 Apr; 25(7):. PubMed ID: 32268564
[TBL] [Abstract][Full Text] [Related]
32. Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells.
Luo F; Li J; Liu J; Liu K
Cancer Gene Ther; 2022 Nov; 29(11):1707-1719. PubMed ID: 35750753
[TBL] [Abstract][Full Text] [Related]
33. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
Huang SM; Mishina YM; Liu S; Cheung A; Stegmeier F; Michaud GA; Charlat O; Wiellette E; Zhang Y; Wiessner S; Hild M; Shi X; Wilson CJ; Mickanin C; Myer V; Fazal A; Tomlinson R; Serluca F; Shao W; Cheng H; Shultz M; Rau C; Schirle M; Schlegl J; Ghidelli S; Fawell S; Lu C; Curtis D; Kirschner MW; Lengauer C; Finan PM; Tallarico JA; Bouwmeester T; Porter JA; Bauer A; Cong F
Nature; 2009 Oct; 461(7264):614-20. PubMed ID: 19759537
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis.
Fujita S; Mukai T; Mito T; Kodama S; Nagasu A; Kittaka M; Sone T; Ueki Y; Morita Y
Bone; 2018 Jan; 106():156-166. PubMed ID: 29055830
[TBL] [Abstract][Full Text] [Related]
35. Tankyrase Inhibitors Target Colorectal Cancer Stem Cells via AXIN-Dependent Downregulation of c-KIT Tyrosine Kinase.
Jang MK; Mashima T; Seimiya H
Mol Cancer Ther; 2020 Mar; 19(3):765-776. PubMed ID: 31907221
[TBL] [Abstract][Full Text] [Related]
36. XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway.
Tian XH; Hou WJ; Fang Y; Fan J; Tong H; Bai SL; Chen Q; Xu H; Li Y
J Exp Clin Cancer Res; 2013 Dec; 32(1):100. PubMed ID: 24308762
[TBL] [Abstract][Full Text] [Related]
37. Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling.
Mariotti L; Templeton CM; Ranes M; Paracuellos P; Cronin N; Beuron F; Morris E; Guettler S
Mol Cell; 2016 Aug; 63(3):498-513. PubMed ID: 27494558
[TBL] [Abstract][Full Text] [Related]
38. Tankyrase inhibition aggravates kidney injury in the absence of CD2AP.
Kuusela S; Wang H; Wasik AA; Suleiman H; Lehtonen S
Cell Death Dis; 2016 Jul; 7(7):e2302. PubMed ID: 27441654
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
Wang W; Liu P; Lavrijsen M; Li S; Zhang R; Li S; van de Geer WS; van de Werken HJG; Peppelenbosch MP; Smits R
Sci Rep; 2021 Apr; 11(1):7470. PubMed ID: 33811251
[TBL] [Abstract][Full Text] [Related]
40. RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model.
Mizutani A; Yashiroda Y; Muramatsu Y; Yoshida H; Chikada T; Tsumura T; Okue M; Shirai F; Fukami T; Yoshida M; Seimiya H
Cancer Sci; 2018 Dec; 109(12):4003-4014. PubMed ID: 30238564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
